Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

First adrenal insufficiency patient dosed in Phase 2 study

pharmatimesFebruary 10, 2022

Tag: adrenal , Diurnal , CAG

PharmaSources Customer Service